Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease

被引:38
|
作者
Javed, Zulqarnain [1 ]
Valero-Elizondo, Javier [2 ,3 ]
Dudum, Ramzi [4 ]
Khan, Safi U. [2 ]
Dubey, Prachi [5 ]
Hyder, Adnan A. [6 ]
Xu, Jiaqiong [2 ,7 ]
Bilal, Usama [8 ,9 ]
Kash, Bita A. [7 ,10 ,11 ]
Cainzos-Achirica, Miguel [1 ,2 ,3 ]
Nasir, Khurram [1 ,2 ,3 ]
机构
[1] Houston Methodist, Ctr Outcomes Res, Div Hlth Equ & Dispar Res, Houston, TX 77030 USA
[2] Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Div Cardiovasc Prevent & Wellness, Houston, TX 77030 USA
[3] Houston Methodist, Ctr Cardiovasc Computat Hlth & Precis Med C3 PH, Houston, TX 77030 USA
[4] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA
[5] Houston Methodist Hosp, Houston Methodist Res Inst, Houston, TX 77030 USA
[6] Georgetown Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA
[7] Houston Methodist, Ctr Outcomes Res, Houston, TX USA
[8] Drexel Dornsife Sch Publ Hlth, Urban Hlth Collaborat, Philadelphia, PA USA
[9] Drexel Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA USA
[10] Weill Cornell Med, New York, NY USA
[11] Texas A&M Univ, Sch Rural Publ Hlth, College Stn, TX USA
来源
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2021年 / 8卷
关键词
ASCVD; Cardiovascular disease; Polysocial risk score; Social determinants of health; SOCIOECONOMIC-STATUS; SOCIAL DETERMINANTS; DEPRESSIVE SYMPTOMS; LIFE-COURSE; MORTALITY; HEALTH; IMPACT; POSITION; MIDDLE; MEN;
D O I
10.1016/j.ajpc.2021.100251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To date, the extent to which social determinants of health (SDOH) may help identify individuals with atherosclerotic cardiovascular disease (ASCVD) - beyond traditional risk factors - has not been quantified using a cumulative social disadvantage approach. The objective of this study was to develop, and validate, a polysocial risk score (PsRS) for prevalent ASCVD in a nationally representative sample of adults in the United States (US). Methods: We used data from the 2013-2017 National Health Interview Survey. A total of 38 SDOH were identified from the database. Stepwise and criterion-based selection approaches were applied to derive PsRS, after adjusting for traditional risk factors. Logistic regression models were fitted to assign risk scores to individual SDOH, based on relative effect size magnitudes. PsRS was calculated by summing risk scores for individual SDOH, for each participant; and validated using a separate validation cohort. Results: Final sample comprised 164,696 adults. PsRS included 7 SDOH: unemployment, inability to pay medical bills, low income, psychological distress, delayed care due to lack of transport, food insecurity, and less than high school education. PsRS ranged from 0-20 and exhibited excellent calibration and discrimination. Individuals with the highest PsRS (5(th) quintile) had nearly 4-fold higher ASCVD prevalence, relative to those with the lowest risk scores (1(st) quintile). Area under receiver operating curve (AU-ROC) for PsRS with SDOH alone was 0.836. Addition of SDOH to the model with only demographic and clinical risk factors (AU-ROC= 0.852) improved overall discriminatory power, with AU-ROC for final PsRS (demographics + clinical + SDOH) = 0.862. Conclusions: Cumulatively, SDOH may help identify individuals with ASCVD, beyond traditional cardiovascular risk factors. In this study, we provide a unique validated PsRS for ASCVD in a national sample of US adults. Future study should target development of similar scores in diverse populations, and incorporate longitudinal study designs.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Validation of the SCORE index and SCORE for old people in the Castilla y Leon cardiovascular disease risk cohort
    Vega Alonso, A. T.
    Ordax Diez, A.
    Lozano Alonso, J. E.
    Alamo Sanz, R.
    Lleras Munoz, S.
    Garcia Palomar, P.
    HIPERTENSION Y RIESGO VASCULAR, 2019, 36 (04): : 184 - 192
  • [42] ECONOMIC BURDEN OF DIABETIC PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR RISK FACTORS FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Marcellusi, A.
    Sciattella, P.
    Bini, C.
    Rotundo, M.
    Aimaretti, G.
    Mennini, F. S.
    VALUE IN HEALTH, 2020, 23 : S509 - S509
  • [43] Determining the level of agreement for atherosclerotic cardiovascular disease risk stratification between coronary artery calcium score and traditional cardiovascular risk models
    Kuria, Menge Issa
    CARDIOVASCULAR JOURNAL OF AFRICA, 2018, 29 : 4 - 5
  • [44] Triglycerides and risk of atherosclerotic cardiovascular disease: An update
    Farnier, Michel
    Zeller, Marianne
    Masson, David
    Cottin, Yves
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2021, 114 (02) : 132 - 139
  • [45] Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
    Jaiswal, S.
    Natarajan, P.
    Silver, A. J.
    Gibson, C. J.
    Bick, A. G.
    Shvartz, E.
    McConkey, M.
    Gupta, N.
    Gabriel, S.
    Ardissino, D.
    Baber, U.
    Mehran, R.
    Fuster, V.
    Danesh, J.
    Frossard, P.
    Saleheen, D.
    Melander, O.
    Sukhova, G. K.
    Neuberg, D.
    Libby, P.
    Kathiresan, S.
    Ebert, B. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (02): : 111 - 121
  • [46] Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk
    Burnett, John R.
    Hooper, Amanda J.
    Hegele, Robert A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (23) : 2736 - 2739
  • [47] Estimation of Atherosclerotic Cardiovascular Disease Risk in Veterans
    Djousse, Luc
    Vassy, Jason L.
    Gagnon, David R.
    Lu, Bing
    Ho, Yuk-Lam
    Costa, Lauren
    Gaziano, J. M.
    Cho, Kelly
    Wilson, Peter W.
    CIRCULATION, 2019, 139
  • [48] Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
    Yu, En
    Hsu, Hsin-Yin
    Huang, Chun-Yuan
    Hwang, Lee-Ching
    OPEN MEDICINE, 2018, 13 (01): : 208 - 213
  • [49] Triglycerides as Residual Risk for Atherosclerotic Cardiovascular Disease
    Ohmura, Hirotoshi
    CIRCULATION JOURNAL, 2019, 83 (05) : 969 - 970
  • [50] Eliminating atherosclerotic cardiovascular disease residual risk
    Makover, Michael E.
    Surma, Stanislaw
    Banach, Maciej
    Toth, Peter P.
    EUROPEAN HEART JOURNAL, 2023, 44 (45) : 4731 - 4733